Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020

SELL
$27.86 - $39.35 $297,934 - $420,808
-10,694 Closed
0 $0
Q2 2020

Jul 27, 2020

SELL
$30.3 - $42.55 $35,451 - $49,783
-1,170 Reduced 9.86%
10,694 $337,000
Q1 2020

May 08, 2020

SELL
$30.0 - $54.18 $112,950 - $203,987
-3,765 Reduced 24.09%
11,864 $417,000
Q4 2019

Feb 04, 2020

SELL
$42.29 - $52.2 $103,018 - $127,159
-2,436 Reduced 13.48%
15,629 $759,000
Q3 2019

Nov 06, 2019

BUY
$42.06 - $51.64 $109,986 - $135,038
2,615 Added 16.93%
18,065 $858,000
Q4 2018

Feb 05, 2019

BUY
$25.26 - $38.43 $2,526 - $3,843
100 Added 0.65%
15,450 $440,000
Q3 2018

Nov 02, 2018

SELL
$33.27 - $39.25 $85,437 - $100,794
-2,568 Reduced 14.33%
15,350 $0
Q2 2018

Aug 10, 2018

SELL
$21.73 - $33.15 $101,413 - $154,711
-4,667 Reduced 20.66%
17,918 $0
Q1 2018

May 09, 2018

BUY
$21.05 - $26.6 $5,262 - $6,650
250 Added 1.12%
22,585 $0
Q4 2017

Feb 22, 2018

SELL
$23.37 - $29.26 $40,897 - $51,205
-1,750 Reduced 7.27%
22,335 $0
Q3 2017

Nov 07, 2017

BUY
$27.25 - $31.55 $13,625 - $15,775
500 Added 2.12%
24,085 $678,000
Q2 2017

Aug 08, 2017

BUY
N/A
23,585
23,585 $760,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.